NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $477,000 | +31.0% | 6,284 | +42.9% | 0.04% | +63.0% |
| Q1 2022 | $364,000 | +0.8% | 4,399 | -8.5% | 0.03% | -27.0% |
| Q4 2021 | $361,000 | -72.2% | 4,808 | -17.8% | 0.04% | -70.6% |
| Q2 2021 | $1,297,000 | +197.5% | 5,846 | +77.2% | 0.13% | +306.5% |
| Q1 2021 | $436,000 | -21.9% | 3,299 | -34.2% | 0.03% | -67.7% |
| Q3 2020 | $558,000 | -56.4% | 5,013 | -75.2% | 0.10% | +28.0% |
| Q2 2019 | $1,280,000 | – | 20,245 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
| HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
| MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
| Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
| Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
| Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
| Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
| Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |